Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_3). Proof of concept

2024-519780-18-00 Protocol IMIMFTCL/ESPAMA_3 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 11 Jun 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol IMIMFTCL/ESPAMA_3

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 21
Countries 1
Sites 1

Healthy volunteers

Key facts

Sponsor
Consorci Mar Parc De Salut De Barcelona
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male
Therapeutic area
Not possible to specify
Trial duration
11 Jun 2025 → ongoing
Decision date (initial)
2025-04-08
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Healthy volunteers

VersionLevelCodeTermSystem organ class
26.0 LLT 10088820 Clinical trial healthy volunteer 100000004848

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Consorci Mar Parc De Salut De Barcelona

Sponsor organisation
Consorci Mar Parc De Salut De Barcelona
Address
Passeig Maritim De La Barceloneta 25-29
City
Barcelona
Postcode
08003
Country
Spain

Scientific contact point

Organisation
Consorci Mar Parc De Salut De Barcelona
Contact name
Ana Maria Aldea Perona

Public contact point

Organisation
Consorci Mar Parc De Salut De Barcelona
Contact name
Marta López Otero

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ongoing, recruiting 21 1
Rest of world 0

Investigational sites

Spain

1 site · Ongoing, recruiting
Consorci Mar Parc De Salut De Barcelona
Hospital del Mar Research Institute, Passeig Maritim De La Barceloneta 25-29, 08003, Barcelona

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2025-06-11 2025-06-11

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-12-19 Spain Acceptable
2025-04-04
2025-04-08
2 SUBSTANTIAL MODIFICATION SM-1 2025-05-14 Spain Acceptable 2025-06-02